Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06565546 · ClinicalTrials.gov registry record · NA
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
A NA study of Ventral Hernia, sponsored by University of Florida.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06565546: Active NA study of Ventral Hernia, sponsored by University of Florida.
NCT06565546 is a NA study of Ventral Hernia that is active but no longer recruiting, run by University of Florida. The registered enrollment target is 100 participants, below the 137-participant average among 18 other Ventral Hernia trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06565546, a NA study of Ventral Hernia, is active but no longer recruiting, sponsored by University of Florida.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot pragmatic trial using an implementation science approach to determine the feasibility of a CYP2D6-guided opioid prescribing for patients undergoing elective VHRs compared to usual care. Assess the efficacy (PROMIS Pain Intensity and Hernia-Related QOL) of a CYP2D6-guided opioid prescribing approach for patients undergoing elective VHRs.
Primary Outcome
Percentage of potential participants approached will enroll and complete study.
Conditions Studied
Interventions
- OTHER Opioid pain medication prescribed based on CYP2D6 genotype testing PLUS Acetaminophen and Gabapentin
- OTHER Acetaminophen and Gabapentin: standard postoperative pain medications
Study Locations (1)
Florida
- University of Florida Jacksonville - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-01-29 |
| Est. Completion | 2026-07 |
| Phase | NA |
What the registry record for NCT06565546 still lists
NCT06565546 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 137-participant average among 18 other Ventral Hernia trials with a reported enrollment target (27% lower).
The record links to 1 condition, with Ventral Hernia appearing as the primary indexed condition, and to 2 interventions - of which Opioid pain medication prescribed based on CYP2D6 genotype testing PLUS Acetaminophen and Gabapentin is the first listed.
NCT06565546 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06565546 about?
NCT06565546 is a clinical study titled "CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs". Pilot pragmatic trial using an implementation science approach to determine the feasibility of a CYP2D6-guided opioid prescribing for patients undergoing elective VHRs compared to usual care. Assess the efficacy (PROMIS Pain Intensity and Hernia-Related QOL) of a CYP2D6-guided opioid prescribing app...
What is the current status of trial NCT06565546?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-01-29. Estimated completion is 2026-07.
What conditions does trial NCT06565546 study?
This clinical trial studies the following conditions: Ventral Hernia.
What interventions are being tested in trial NCT06565546?
The interventions under investigation include: Opioid pain medication prescribed based on CYP2D6 genotype testing PLUS Acetaminophen and Gabapentin (OTHER), Acetaminophen and Gabapentin: standard postoperative pain medications (OTHER).
Who is sponsoring clinical trial NCT06565546?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06565546 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventral Hernia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06565546's enrollment target sits among peer trials
100 12th of 18 higher than 7 of 18 other Ventral Hernia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventral Hernia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
RECRUITING · NA
-
Robotic Versus Open Ventral Hernia Repair
RECRUITING · NA
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Hernia Surgery (Enable Hernia Repair)
ACTIVE NOT RECRUITING · NA
-
Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair
ACTIVE NOT RECRUITING · NA
-
Mesh Type in Ventral Hernia Repair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI